ArticleQuantitative imaging in medicine and surgery2025
Quantitative synthetic MRI reveals grey matter abnormalities in patients with spinal muscular atrophy types 2 and 3.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several studies have shown that spinal muscular atrophy (SMA) is not limited to lower motor neurons. This cross-sectional study aimed to quantitatively investigate the gray matter (GM) alterations in patients with SMA types 2 and 3. Methods: This is a cross-sectional study. T1 and T2 maps that were extracted from synthetic magnetic resonance imaging (SyMRI) were compared between patients with SMA and healthy controls (HC). Between-group comparisons were made between SMA type 2 and type 3. The association between brain regions with significantly altered T1 and T2 values and clinical measurements were evaluated with Pearson correlation analysis. Results: Compared with HC, patients with SMA showed widespread altered T1 and T2 values in GM, mainly referring to the cerebellum, default mode network, attention and execution control network, and salience network. Negative correlations were found between Hammersmith Functional Motor Scale Expanded (HFMSE) scores and T2 values of the left orbital part of superior frontal gyrus (P=0.013) and the right olfactory cortex (P=0.008) in the patient group. Conclusions: Altered T1 and T2 values involving multiple GM regions of the brain demonstrate widespread microscopic alterations in patients with SMA, which might provide an idea for quantitative measurement of SMA nerve damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.